Cargando…
A current perspective on applications of macrocyclic‐peptide‐based high‐affinity ligands
Monoclonal antibodies can bind with high affinity and high selectivity to their targets. As a tool in therapeutics or diagnostics, however, their large size (∼150 kDa) reduces penetration into tissue and prevents passive cellular uptake. To overcome these and other problems, minimized protein scaffo...
Autores principales: | Leenheer, Daniël, ten Dijke, Peter, Hipolito, Christopher John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5132055/ https://www.ncbi.nlm.nih.gov/pubmed/27352774 http://dx.doi.org/10.1002/bip.22900 |
Ejemplares similares
-
A Macrocyclic Peptide that Serves as a Cocrystallization Ligand and Inhibits the Function of a MATE Family Transporter
por: Hipolito, Christopher J., et al.
Publicado: (2013) -
A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
por: Huynh, Linh Khanh, et al.
Publicado: (2019) -
Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands
por: Bowen, John, et al.
Publicado: (2021) -
Computational Macrocyclization: From de novo Macrocycle Generation to Binding Affinity Estimation
por: Wagner, Vincent, et al.
Publicado: (2017) -
High-affinity peptides developed against calprotectin and their application as synthetic ligands in diagnostic assays
por: Díaz-Perlas, Cristina, et al.
Publicado: (2023)